Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Sanofi pays SK $52M as children's pneumococcal shot enters ph. 3
Sanofi is handing SK bioscience 50 million euros ($52 million) to take their next-gen pneumococcal conjugate vaccine program into phase 3.
James Waldron
Dec 23, 2024 8:05am
Sanofi scoops up China rights to Cytokinetics' heart disease med
Dec 20, 2024 11:07am
Oncology biotech licenses Genevant tech for up to $123M
Dec 20, 2024 6:00am
Idorsia's Tryvio sale behind schedule, but layoffs on track
Dec 20, 2024 4:42am
VC firm pens $608M deal to direct NGM MASH drug to rare disease
Dec 19, 2024 10:30am
Astellas pays Sangamo $20M to boost neurological gene therapies
Dec 19, 2024 7:13am
